Diseases of Pulmonary Vasculature

Right Atrium Enlargement Predicts Supraventricular Arrhythmia Risk in PAH

Right Atrium Enlargement Predicts Supraventricular Arrhythmia Risk in PAH

By

Right atrium enlargement may predict the risk for supraventricular arrhythmias in patients with pulmonary arterial hypertension.

Long-Term Prognosis in Women vs Men With Pulmonary Arterial Hypertension

Long-Term Prognosis in Women vs Men With Pulmonary Arterial Hypertension

By

Women with pulmonary arterial hypertension may have better long-term prognoses compared with men, potentially because of improvements in right ventricular function.

Peripheral Artery Disease, DVT Risk May Increase With Varicose Veins

Peripheral Artery Disease, DVT Risk May Increase With Varicose Veins

Varicose veins significantly increased the risk for deep vein thrombosis and may also increase the risk for pulmonary embolism and peripheral artery disease.

Pulmonary Embolism Rule-Out Criteria Can Identify Thromboembolic Events

Pulmonary Embolism Rule-Out Criteria Can Identify Thromboembolic Events

By

A 3-month risk for a thromboembolic event was assessed using a pulmonary embolism rule-out criteria strategy and compared with a conventional strategy in patients with a low clinical probability of pulmonary embolism.

Pulmonary Embolism With Low Mortality Risk Treated in Outpatient Setting

Pulmonary Embolism With Low Mortality Risk Treated in Outpatient Setting

By

Acute pulmonary embolism may be managed in an outpatient setting when the patient has a low risk for mortality.

Idiopathic PAH-Associated Hypoxemia Linked to Poor Survival, Increased Comorbidities

Idiopathic PAH-Associated Hypoxemia Linked to Poor Survival, Increased Comorbidities

By

Hypoxemia is associated with reduced survival in patients with idiopathic or heritable pulmonary arterial hypertension.

Peak Circulatory Power Is a Potent Predictive Tool in Idiopathic PAH

Peak Circulatory Power Is a Potent Predictive Tool in Idiopathic PAH

By

Peak circulatory may provide reliable prognostic information in patients with idiopathic pulmonary arterial hypertension.

6MWT Clinically Relevant and Appropriate Prognostic Tool for PAH

6MWT Clinically Relevant and Appropriate Prognostic Tool for PAH

By

The 6MWT is a clinically relevant and appropriate target for patients with pulmonary arterial hypertension.

Pulmonary Embolism Risk Prediction in Postpartum Women

Pulmonary Embolism Risk Prediction in Postpartum Women

By

Certain risk scores may not be reliable for predicting the presence of a pulmonary embolism in pregnant or postpartum women.

Two 6-Minute Walk Tests Recommended for Suspected Pulmonary Hypertension

Two 6-Minute Walk Tests Recommended for Suspected Pulmonary Hypertension

By

To minimize the "learning effect" and improve accuracy, patients with suspected pulmonary hypertension should undergo two 6-minute walk tests.

Pilot Study to Assess Effectiveness of Milrinone in Congenital Diaphragmatic Hernia

Pilot Study to Assess Effectiveness of Milrinone in Congenital Diaphragmatic Hernia

By

A pilot study will assess the effectiveness of milrinone in a small group of infants born with congenital diaphragmatic hernia.

Pulmonary Hypertension vs Age for Predicting Outcomes in Heart Transplant

Pulmonary Hypertension vs Age for Predicting Outcomes in Heart Transplant

By

Compared with age, pulmonary hypertension, right ventricular failure, and cardiopulmonary bypass time may better predict outcomes in heart transplantation.

Implantable Treprostinil Delivery System Shows Promise for Managing PAH

Implantable Treprostinil Delivery System Shows Promise for Managing PAH

By

Treprostinil, a prostacyclin derivative, used in an implantable delivery system may be an effective treatment alternative for pulmonary arterial hypertension.

PAH Long-Term Survival Predicted by Reliable Risk Calculator

PAH Long-Term Survival Predicted by Reliable Risk Calculator

By

Researchers examined the effect of riociguat compared with placebo on the REVEAL risk score and long-term outcomes for pulmonary arterial hypertension.

Smoke-Free Ordinances Lower Lung Cancer Risk

Smoke-Free Ordinances Lower Lung Cancer Risk

By

Smoke-free ordinances may reduce the number of lung cancer cases.

PAH: eGFR Changes May Predict Survival, Hospitalizations

PAH: eGFR Changes May Predict Survival, Hospitalizations

By

A decrease in baseline estimated glomerular filtration rate in PAH may be a predictor of hospitalization and mortality.

Intermediate-Risk Pulmonary Emboli: Catheter-Directed vs Systemic Thrombolysis

Intermediate-Risk Pulmonary Emboli: Catheter-Directed vs Systemic Thrombolysis

By

Catheter-directed thrombolysis vs systemic thrombolysis strategies show different risk outcomes for patients with intermediate-risk pulmonary embolism.

Pediatric Pulmonary Embolism: 9 Predictors Identified

Pediatric Pulmonary Embolism: 9 Predictors Identified

By

Several clinical predictors of pediatric pulmonary embolism have been identified.

Worsening Shortness of Breath in a 40-Year-Old Woman: A Case Study

Worsening Shortness of Breath in a 40-Year-Old Woman: A Case Study

By

A 40-year-old woman presents with worsening shortness of breath after being treated with long-acting nifedipine for 2 years.

Pulmonary Arterial Hypertension: Mechanisms of Exercise Intolerance

Pulmonary Arterial Hypertension: Mechanisms of Exercise Intolerance

By

Exercise intolerance is a hallmark symptom of pulmonary arterial hypertension.

Impaired Cerebral Pressure-Flow Link in Pulmonary Arterial Hypertension

Impaired Cerebral Pressure-Flow Link in Pulmonary Arterial Hypertension

By

Patients with pulmonary arterial hypertension may have an impaired cerebral pressure-flow relationship.

Improving Pulmonary Arterial Compliance in PAH: Riociguat vs PDE5 Inhibitors

Improving Pulmonary Arterial Compliance in PAH: Riociguat vs PDE5 Inhibitors

By

Switching from a phosphodiesterase type 5 inhibitor to riociguat significantly improves pulmonary arterial compliance in patients with PAH.

Predicting Mortality in PAH With Congenital Heart Disease

Predicting Mortality in PAH With Congenital Heart Disease

By

Pulmonary artery compliance may be an independent predictor of survival and prognosis in patients with pulmonary artery hypertension associated with congenital heart disease.

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

Nebulized Glycopyrrolate Improves Lung Function in Severe COPD With CV Risk Factors

By

Nebulized glycopyrrolate improves lung function and patient-reported outcomes in patients with moderate to very severe COPD.

Methamphetamine-Associated PAH Worse Than Idiopathic PAH

Methamphetamine-Associated PAH Worse Than Idiopathic PAH

By

Pulmonary arterial hypertension associated with the use of methamphetamine is a severe, progressive form of the disease.

Echocardiographic Evaluation Recommended for Hereditary Hemorrhagic Telangiectasia

Echocardiographic Evaluation Recommended for Hereditary Hemorrhagic Telangiectasia

By

Patients with hereditary hemorrhagic telangiectasia may develop pulmonary hypertension.

Chronic Thromboembolic Pulmonary Hypertension, PAH Linked to Depression

Chronic Thromboembolic Pulmonary Hypertension, PAH Linked to Depression

By

Patients with chronic thromboembolic pulmonary hypertension may have higher rates of depression compared to patients with PAH.

Prognostic Value of CT Signs of Pulmonary Veno-occlusive Disease

Prognostic Value of CT Signs of Pulmonary Veno-occlusive Disease

By

Having at least 2 features of pulmonary veno-occlusive disease is linked to reduced survival rate in patients with SSc and PAH.

Borderline Pulmonary Hypertension Commonly Found During Right Heart Catheterization

Borderline Pulmonary Hypertension Commonly Found During Right Heart Catheterization

Borderline pulmonary hypertension is associated with increased risk of mortality in patients undergoing right heart catheterization.

Chronic Thromboembolic PH Diagnosis and Management Update: Expert Q&A

Chronic Thromboembolic PH Diagnosis and Management Update: Expert Q&A

By

Development of CTEPH is associated with traditional thrombotic risk factors, including thrombophilias and inflammatory processes.

Sign Up for Free e-Newsletters